Watch DYN. Know when insiders buy.
One email the day a filing lands. Free.
DYN
Dyne Therapeutics, Inc.
20.31
−3.97 −16.35%
USD · close Sep 8
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
48
WATCH · insiders 39, shorts 56
Insiders, 90 days
−$248K
net selling · 0 buys, 5 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $3.8BP/E —DIV YIELD —FCF YIELD -12.67%REV TTM —NET INCOME −$519.4MNET CASH $476.8M52W 12.37 – 26.78SEC XBRL · TTM TO Invalid Date
Insider trading
−$248K
Net, 90 days
0 / 5
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8 | Sep 8 | Friedl-Naderer Johanna · Chief Commercial Officer | Sell | 185 | $18.88 | $3K |
| Sep 8 | Sep 8 | Kerr Douglas · Chief Medical Officer | Sell | 1,290 | $18.88 | $24K |
| Sep 8 | Sep 8 | Cox John · CEO & President | Sell | 5,658 | $18.88 | $107K |
| Sep 4 | Sep 8 | Friedl-Naderer Johanna · Chief Commercial Officer | Sell | 900 | $24.35 | $22K |
| Sep 4 | Sep 8 | Kerr Douglas · Chief Medical Officer | Sell | 3,745 | $24.35 | $91K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.